Federal Reserve Bank of New York
What do drug monopolies cost consumers in developing countries?
This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
Cite this item
Rebecca Hellerstein, What do drug monopolies cost consumers in developing countries?, Federal Reserve Bank of New York, Staff Reports 530, 2011.
Keywords: Pharmaceutical industry ; Drugs ; Prices ; Developing countries
This item with handle RePEc:fip:fednsr:530
is also listed on EconPapers
For corrections, contact Amy Farber ()